<http://schema.org/articleBody>
" Botox has been approved as a treatment for patients with chronic migraine. The toxin has been licensed by the Medicines and Healthcare Products Regulatory Agency (MHRA) for adults with chronic migraine, which includes headaches on at least 15 days per month and migraine symptoms on at least eight of these days. The approval makes Botox the first preventative treatment to receive a specific licence for use in patients with chronic migraine. It follows a large phase-III clinical trial involving 1,384 patients, which found that patients who received Botox injections into specific head and neck muscles typically had fewer headache and migraine days than those who were given injections of a placebo (dummy treatment). Wendy Thomas, chief executive of the Migraine Trust, commented: &amp;#039;Chronic migraine is currently an under-researched, under-diagnosed and under-treated condition. &amp;#039;We welcome new therapies, especially preventative medication, for this potentially disabling condition.&amp;#039; NHS figures suggest that about 15 per cent of UK adults are affected by migraine. "^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.netdoctor.co.uk/healthy-living/news/a19780/botox-licensed-to-treat-migraine/>